M. Tani

发表

Mutation analysis of coding sequences of the entire transforming growth factor beta type II receptor gene in sporadic human colon cancer using genomic DNA and Intron primers

J. Yokota, C. Harris, W. Bennett, 1997, Oncogene.

Mutation analysis of the Smad2 gene in human colon cancers using genomic DNA and intron primers.

J. Yokota, C. Harris, W. Bennett, 1998, Carcinogenesis.

Activation of the AKT and STAT3 pathways and prolonged survival by a mutant EGFR in human lung cancer cells.

J. Yokota, S. Matsumoto, H. Akça, 2006, Lung cancer.

Infrequent mutations of the transforming growth factor beta-type II receptor gene at chromosome 3p22 in human lung cancers with chromosome 3p deletions.

J. Yokota, C. Harris, T. Kohno, 1997, Carcinogenesis.

Orthotopic growth and metastasis of human non-small cell lung carcinoma cell injected into the pleural cavity of nude mice.

J. Yokota, H. Tsuda, Y. Niitsu, 1998, Cancer letters.

Catheter-delivered in vivo gene transfer into rat myocardium using the fusigenic liposomal mediated method.

M. Aoki, T. Ogihara, Y. Kaneda, 2000, Japanese heart journal.

Suicidal gene therapy for pleural metastasis of lung cancer by liposome-mediated transfer of herpes simplex virus thymidine kinase gene

J. Yokota, Teruhiko Yoshida, K. Shimizu, 1999, Cancer Gene Therapy.

Identification of genes differentially expressed in association with metastatic potential of K-1735 murine melanoma by messenger RNA differential display.

J. Yokota, N. Shindo-Okada, Y. Hashimoto, 1996, Cancer research.

g -Catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of b -catenin

Kathleen R. Cho, E. Fearon, F. Kolligs, 2000 .

RER phenotype and its associated mutations in familial gastric cancer.

J. Yokota, H. Sugimura, K. Shinmura, 1998, Carcinogenesis.

E‐cadherin gene variants in gastric cancer families whose probands are diagnosed with diffuse gastric cancer

J. Yokota, T. Nakajima, H. Katai, 2002, International journal of cancer.

HOMER2 binds MYO18B and enhances its activity to suppress anchorage independent growth.

J. Yokota, K. Sutoh, M. Maeda, 2007, Biochemical and biophysical research communications.

MYO18B interacts with the proteasomal subunit Sug1 and is degraded by the ubiquitin-proteasome pathway.

J. Yokota, K. Sutoh, T. Kon, 2006, Biochemical and biophysical research communications.

Isolation of a novel Sry-related gene that is expressed in high-metastatic K-1735 murine melanoma cells.

J. Yokota, S. Takenoshita, Y. Nagamachi, 1997, Genomics.

Expression of the Elm1 Gene, a Novel Gene of the CCN (Connective Tissue Growth Factor, Cyr61/Cef10, and Neuroblastoma Overexpressed Gene) Family, Suppresses In Vivo Tumor Growth and Metastasis of K-1735 Murine Melanoma Cells

J. Yokota, N. Shindo-Okada, T. Shiroishi, 1998, The Journal of experimental medicine.

Genetic and epigenetic alterations of the candidate tumor‐suppressor gene MYO18B, on chromosome arm 22q, in colorectal cancer

J. Yokota, A. Otsuka, T. Kohno, 2005, Genes, chromosomes & cancer.

Genetic alterations responsible for metastatic phenotypes of lung cancer cells

J. Yokota, T. Kohno, M. Tani, 2004, Clinical & Experimental Metastasis.

Pathogenetic and biologic significance of TP14ARF alterations in nonsmall cell lung carcinoma.

J. Yokota, T. Kohno, K. Shimizu, 2003, Cancer Genetics and Cytogenetics.

Mutation and expression of the p51 gene in human lung cancer.

J. Yokota, T. Kohno, C. Kawahara, 1999, Neoplasia.

MYO18B, a candidate tumor suppressor gene at chromosome 22q12.1, deleted, mutated, and methylated in human lung cancer

J. Minna, N. Yanaihara, J. Yokota, 2002, Proceedings of the National Academy of Sciences of the United States of America.

γ-Catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of β-catenin

Kathleen R. Cho, Eric R. Fearon, E. Fearon, 2000, Genes & Development.

Establishment of human osteosarcoma cell lines with high metastatic potential to lungs and their utilities for therapeutic studies on metastatic osteosarcoma

J. Yokota, H. Moriya, H. Tsuda, 2004, Clinical & Experimental Metastasis.

Biological properties and gene expression associated with metastatic potential of human osteosarcoma

J. Yokota, S. Ohwada, K. Aoyagi, 2004, Clinical & Experimental Metastasis.

Correlation between histone acetylation and expression of the MYO18B gene in human lung cancer cells

Masahiko Shiraishi, Jun Yokota, Takashi Kohno, 2004, Genes, chromosomes & cancer.

The autocrine motility factor receptor gene encodes a novel type of seven transmembrane protein 1

J. Yokota, A. Raz, S. Ohwada, 1999, FEBS letters.

Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA

J. Yokota, T. Kohno, H. Sugimura, 1998, Oncogene.

Molecular cloning of a novel NF2/ERM/4.1 superfamily gene, ehm2, that is expressed in high-metastatic K1735 murine melanoma cells.

J. Yokota, K. Shimizu, Y. Nagamachi, 2000, Genomics.

Genomic structure and chromosomal localization of the mouse Ogg1 gene that is involved in the repair of 8-hydroxyguanine in DNA damage

S. Wakana, J. Yokota, T. Kohno, 2009, Mammalian Genome.

Enhancement of OGG1 protein AP lyase activity by increase of APEX protein.

J. Yokota, S. Yamaguchi, K. Shinmura, 2001, Mutation research.

gamma-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin.

E. Fearon, K. Cho, F. Kolligs, 2000, Genes & development.

Absence of mutations in the analysis of coding sequences of the entire transforming growth factor-beta type II receptor gene in sporadic human breast cancers.

Y. Nagamachi, H. Osawa, T. Koida, 1998, Oncology reports.

Loss of CDX2 expression and microsatellite instability are prominent features of large cell minimally differentiated carcinomas of the colon.

Kathleen R. Cho, M. Loda, R. Dunn, 2001, The American journal of pathology.

Restored expression of the MYO18B gene suppresses orthotopic growth and the production of bloody pleural effusion by human malignant pleural mesothelioma cells in SCID mice.

J. Yokota, S. Sone, S. Yano, 2006, Oncology Research.